UNITED THERAPEUTICS Corp — Director's Dealing 2021

Oct 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-10-21

Reporting Person: MAHON PAUL A (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-21	Common Stock	M	6000	$111.00	Acquired	42369	Direct
2021-10-21	Common Stock	S	3000	$189.794	Disposed	39369	Direct
2021-10-21	Common Stock	S	3000	$190.5665	Disposed	36369	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-21	Stock Options	$111.00	M	6000	Disposed	2028-03-15	Common Stock (6000)	Direct

Footnotes

F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.

F2: This transaction was executed in multiple trades at prices ranging from $189.17 to 190.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $191.13 to 190.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.